Q&A: The development of an AI solution to diagnose COVID-19 pneumonia

In response to the COVID-19 outbreak, AI company BioMind developed a solution (BioMind AI-COVID) with the aim of diagnosing COVID-19 Pneumonia in a fast, accurate and cost-effective manner. It has since been deployed in hospitals across China, and is intent on expanding its footprint globally. Ian Bolland found out more. Give us some background about BioMind – who developed it? BioMind is an award-winning Artificial Intelligence company that specialises in creating predictive applications to assist doctors in their daily work.